Clinical Trials Browser

Interventional × Recurrence × tirabrutinib × Clear all

NCT02457559 2022-03-24

Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies

Phase 1 Completed

29 enrolled 24 charts

Recurrence